A vaccine against COVID-19, developed by Valneva, has received regulatory approval from the Medicines and Health Products Regulatory Agency (MHRA).
This is the sixth coronavirus vaccine to be authorized for MHRA.
The UK’s independent drug regulator is the first in the world to approve the Valneva product, according to a statement from the Medicines and Health Products Regulatory Agency (MHRA).
MHRA CEO Dr June Raine said: “Our approval of the COVID-19 vaccine made by Valneva today follows a careful review of the safety, quality and efficacy of this vaccine and expert advice from the government’s independent scientific advisory body, the Commission. on Human Medicines. “
Valneva jab is the first virus-inactivated vaccine against COVID-19 to receive regulatory approval in the United Kingdom.
With this type of vaccine, the virus is grown in a laboratory and then made completely inactive so that it cannot infect cells or replicate in the body, but can still trigger an immune response to the COVID-19 virus.
This vaccine-making process is already widely used in the production of influenza and polio vaccines, the MHRA said.
Valneva’s approval comes as the number of coronavirus-related deaths recorded each week in England and Wales continues to rise, although levels remain well below those reached during previous waves of the virus.
Add Comment